| Old Articles: <Older 22871-22880 Newer> |
|---|
 |
The Motley Fool
May 2, 2007
Brian Lawler |
Progenics' Intriguing Study Results The development-stage drugmaker released clinical trial results for one of its compounds. Investors, take note.   |
The Motley Fool
May 2, 2007
Tim Beyers |
Who's Buying Now? Sometimes insiders are buying for all the right reasons. Who's at it this week? Capitol Bancorp... Pentair... Popular... Parker-Hannifin... Security Bank Corp... etc. |
The Motley Fool
May 2, 2007
Timothy M. Otte |
P&G Loses the Expectations Game Analysts aren't impressed with the conglomerate's third-quarter results. Investors, take note. |
The Motley Fool
May 2, 2007
Emil Lee |
Bend It Like Buffett: Dissecting Torchmark The pattern seems clear. Warren Buffett buys shares in extremely high-quality companies when he can get them at a discount. The rewards for his patience often result in years and years of stellar returns. |
The Motley Fool
May 2, 2007
Brian Lawler |
BioMarin Moves Ahead The drug developer released first-quarter financial results. Even though BioMarin is not yet profitable, its management team has proven capable in all areas of drug development, from the clinical stage to commercialization. Investors, take note. |
The Motley Fool
May 2, 2007
Brian Lawler |
Biogen's Measured Growth The biopharmaceutical reports first-quarter financial results. Investors, take note. |
The Motley Fool
May 2, 2007
Rick Aristotle Munarriz |
Denny's the Menace The value-minded casual-dining chain slips in a greasy kitchen. The company posted lackluster results last night. Revenue fell by 4% to $236.8 million, as the casual-dining operator posted a small loss before realizing an asset-sale gain. |
The Motley Fool
May 2, 2007
Anders Bylund |
Too Much Total Access at Blockbuster? The video rental company's pride and joy is also its biggest liability. Investors, take note. |
The Motley Fool
May 2, 2007
Ryan Fuhrmann |
Navteq Travels Upward: Fool by Numbers The digital map database and software firm released first-quarter 2007 results. Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
May 2, 2007
Brian Lawler |
Vanda Advancing The development-stage biotech releases first-quarter financial results. Investors, take note. |
| <Older 22871-22880 Newer> Return to current articles. |
